Guidant Corp.

Recent Events

News & Analysis

acquisition and guidant corp. - All News and Analysis

• Abbott closes deal for Guidant biz.(Briefs)(Abbott Laboratories Inc.)(acquisition )(Brief article)

  - 2006-04-24

  Abbott Laboratories closed its acquisition of Guidant's vascular intervention and endovascular businesses as Boston Scientific completed its deal to buy the rest of Guidant. Meanwhile, Abbott said first-quarter profit rose 3.2% as higher gross margin Abbott Laboratories closed its acquisition of Guidant's vascular intervention and...

  Tags: Abbott Laboratories Inc., acquisition, Guidant Corp.

• Fitch Downgrades Boston Scientific Corp. to 'BBB' After Guidant Acquisition

  - 2006-04-21

  CHICAGO -- Fitch Ratings has downgraded Boston Scientific Corp. BSX following today's completion of the company's $29 billion acquisition of Guidant Corp. (including approximately $90 million in interest paid to Guidant shareholders).

  Tags: acquisition, Boston Scientific Corp., Guidant Corp.

• Fitch Expects to Downgrade Boston Scientific to 'BBB'; Stable Outlook After Guidant Acquisition

  - 2006-02-10

  CHICAGO -- Fitch Ratings has completed its review of the anticipated capital structure, business prospects, and cash flow of Boston Scientific Corp. BSX on a pro forma basis assuming the company's $27.5 billion acquisition of Guidant Corp. GDT is approved and completed. The transaction is contingent upon Federal Trade Commission...

  Tags: acquisition, Boston Scientific Corp., Fitch, Guidant Corp.

• Guidant Acquisition Changes VC Investment Landscape for Medical Devices; Future Start-ups Must be ''Built to Last'' Rather Than ''Built to Sell,'' Says ONSET Ventures Partner

  - 2006-02-01

  MENLO PARK, Calif. -- The recent acquisition of Guidant GDT by Boston Scientific BSX will impact future venture-capital start-up investments in medical devices, said ONSET Ventures general partner Rob Kuhling. The popular strategy of incubating new technologies as start-ups and then selling them to large, established players will become increasingly...

  Tags: acquisition, Guidant Corp., medical device

• Fitch: Abbott Laboratories' Ratings Unchanged After Acquisition Announcement

  - 2006-01-09

  CHICAGO -- Fitch Ratings does not expect the ratings and Outlook for Abbott Laboratories Abbott to change in light of the company's announcement of its intention to acquire Guidant's Guidant Corporation vascular business for approximately $3.8 billion in cash in addition to providing Boston Scientific Corporation Boston Scientific with a...

  Tags: Abbott Laboratories Inc., acquisition, Boston Scientific Corp., Guidant Corp.

• Head and heart; Health care.(acquisition bid for Guidant Corp. by Johnson & Johnson and Boston Scientific)

  - 2005-12-10

  The battle for Guidant The battle for Guidant

  Tags: acquisition, Boston Scientific Corp., Guidant Corp., health care, Johnson & Johnson

• Federal Trade Commission Clears Johnson & Johnson's Acquisition of Guidant

  - 2005-11-02

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the Federal Trade Commission FTC has agreed to terminate the Hart-Scott-Rodino HSR Act waiting period applicable to Guidant's pending acquisition by Johnson & Johnson. Under the terms of the merger agreement,...

  Tags: acquisition, FTC, Guidant Corp., Johnson & Johnson

• Guidant Announces European Clearance of Acquisition; European Commission Ruling Necessitates Organizational and Staffing Adjustments

  - 2005-08-25

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) today announced that as a result of the European Commission ruling approving the merger with Johnson & Johnson, it is implementing a number of organizational changes to facilitate the divestiture of Guidant's Endovascular Solutions operations in Europe. The remainder of Guidant's European operations is not...

  Tags: acquisition, European Commission, Guidant Corp., staffing

• Johnson & Johnson Announces European Commission Clearance of Guidant Acquisition.

  - 2005-08-25

  NEW BRUNSWICK, New Jersey, August 25 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) has been notified that the European Commission has cleared its proposed acquisition of Guidant Corporation (NYSE: GDT). NEW BRUNSWICK, New Jersey, August 25 /PRNewswire/ -- ...

  Tags: Guidant Corp., NYSE Euronext, Johnson & Johnson, European Commission, acquisition

• Guidant Shareholders Overwhelmingly Approve Acquisition Agreement with Johnson & Johnson

  - 2005-04-27

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) announced that at a special meeting of shareholders held today in Indianapolis, Guidant shareholders overwhelmingly approved the agreement whereby Johnson & Johnson will acquire Guidant for $76 per share or $25.4 billion in fully diluted equity. The agreement, which was announced on December 15, 2004,...

  Tags: acquisition, Guidant Corp., Johnson & Johnson, shareholder